These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 31323186

  • 1. Intracellular targets as source for cleaner targets for the treatment of solid tumors.
    Gerber HP, Sibener LV, Lee LJ, Gee M.
    Biochem Pharmacol; 2019 Oct; 168():275-284. PubMed ID: 31323186
    [Abstract] [Full Text] [Related]

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E, Fernández-Medarde A.
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [Abstract] [Full Text] [Related]

  • 3. Combining antibody-drug conjugates and immune-mediated cancer therapy: What to expect?
    Gerber HP, Sapra P, Loganzo F, May C.
    Biochem Pharmacol; 2016 Feb 15; 102():1-6. PubMed ID: 26686577
    [Abstract] [Full Text] [Related]

  • 4. Identification of Antigenic Targets.
    Gerber HP, Sibener LV, Lee LJ, Gee MH.
    Trends Cancer; 2020 Apr 15; 6(4):299-318. PubMed ID: 32209445
    [Abstract] [Full Text] [Related]

  • 5. Investigational antibody drug conjugates for solid tumors.
    Sapra P, Hooper AT, O'Donnell CJ, Gerber HP.
    Expert Opin Investig Drugs; 2011 Aug 15; 20(8):1131-49. PubMed ID: 21599617
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antibody-Drug Conjugates: A Review on the Epitome of Targeted Anti- Cancer Therapy.
    Hasan M, Alam S, Poddar SK.
    Curr Clin Pharmacol; 2018 Aug 15; 13(4):236-251. PubMed ID: 30073930
    [Abstract] [Full Text] [Related]

  • 10. TCR-mimic antibody-drug conjugates targeting intracellular tumor-specific mutant antigen KRAS G12V mutation.
    Shen Y, Wei X, Jin S, Wu Y, Zhao W, Xu Y, Pan L, Zhou Z, Chen S.
    Asian J Pharm Sci; 2020 Nov 15; 15(6):777-785. PubMed ID: 33363632
    [Abstract] [Full Text] [Related]

  • 11. Antibody-targeted drugs and drug resistance--challenges and solutions.
    Shefet-Carasso L, Benhar I.
    Drug Resist Updat; 2015 Jan 15; 18():36-46. PubMed ID: 25476546
    [Abstract] [Full Text] [Related]

  • 12. Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens.
    Wagner S, Mullins CS, Linnebacher M.
    World J Gastroenterol; 2018 Dec 28; 24(48):5418-5432. PubMed ID: 30622371
    [Abstract] [Full Text] [Related]

  • 13. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R, Al-Khadairi G, Roelands J, Hendrickx W, Dermime S, Bedognetti D, Decock J.
    Front Immunol; 2018 Dec 28; 9():947. PubMed ID: 29770138
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities.
    Belfiore L, Saunders DN, Ranson M, Thurecht KJ, Storm G, Vine KL.
    J Control Release; 2018 May 10; 277():1-13. PubMed ID: 29501721
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibody-drug conjugates: Promising and efficient tools for targeted cancer therapy.
    Nasiri H, Valedkarimi Z, Aghebati-Maleki L, Majidi J.
    J Cell Physiol; 2018 Sep 10; 233(9):6441-6457. PubMed ID: 29319167
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.